Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

Clinical Pathology > Theme 7 Haematology: Acquired Bleeding Disorders > Flashcards

Theme 7 Haematology: Acquired Bleeding Disorders Flashcards

1
Q

Name the anticoagulants?

A
  • heparin
  • fondaparinux
  • vitamin K antagonists: warfarin
  • DOACs (direct oral anticoagulants) - rivaraoxaban, dabigatran
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Why do we use anticoagulants?

A
  • prevention of venous thromboembolism
  • prevention of stroke in AF
  • treatment of VTE
  • mechanical valve patients
  • arterial thrombosis/ limb ischaemia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is the mode of action of heparin?

A

increases ability of antithrombin to bind to and irreversibly switch off thrombin (IIa), factor Xa and factor IXa and Xa
(prevents fibrinogen being converted by thrombin to fibrin)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What does unfractionated heparin mean?

A

heparin of different sizes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are the differences in low molecular weight heparin and unfractionated heparin?

A
  • low molecular weight heparin switches off factor Xa
  • unfractionated heparin works against factor Xa and also switches off thrombin
  • LMWH doesn’t inhibit platelet function whereas unfractionated heparin does
  • LMWH is give subcutaneously, has a longer half life and is excreted by the kidneys
  • unfractionated heparin is excreted by the kidneys and liver
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are 3 complications of heparin?

A
  1. Skin/ allergic reactions
  2. Osteoporosis
  3. Heparin induced thrombocytopenia (HIT)
    - heparin interacts with platelets and causes a drop
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is the 4Ts pre test probability score?

A
  • system for assessing heparin induced thrombocytopenia
    1. Thrombocytopenia: extent of fall in platelet count
    2. Timing: onset of fall in platelet count
    3. Thrombosis or other sequelae
    4. Other cause of thrombocytopenia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What happens if a patient starts bleeding on unfractionated heparin or fondaparinux?

A

stop treatment

give antidote if possible

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Which clotting factors are vitamin K dependant?

A

II, VII, IX, X, protein C and S

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is INR?

A

-international normalised ratio
-to control dose of oral anticoagulants
INR = (prothrombin ratio)^ISI

ISI = correction factor to account for sensitivity of thromboplastin compared with the international reference preparation (IRP)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is the prothrombin ratio?

A

prothrombin ratio = patients prothrombin time / mean normal prothrombin time

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

How do you treat excess warfarin if the patient is bleeding?

A

stop warfarin
give prothrombin complex concentrate
give vitamin K IV

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What are the ideal characteristics of an anticoagulant?

A
  • oral administration
  • no requirement for routine coagulation monitoring and dose adjustment
  • wide therapeutic window: high efficacy in preventing thrombosis, low bleeding risk
  • rapid onset of action
  • predictable pharmacokinetics and pharmacodynamics
  • minimal interactions with food
  • availability of an antidote
  • acceptable costs
  • no unexpected toxicities
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Which DOACs inhibit Factor Xa

A
  • rivaroXAban
  • apiXAban
  • edoXAban
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Which DOACs inhibit thrombin?

A

dabigatran

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Do DOACs have a predictable dose-response?

A

yes (compared to warfarin where the dose varies 40 fold)

  • in DOACs, the dose is uniform for most patients
  • no need for routine monitoring
  • minimal interactions with drugs
17
Q

Why can dabigatran not be given to a patient with renal impairment?

A

it is excreted by the kidneys

18
Q

What are the specific contraindications and cautions for DOACs?

A
  • renal impairment
  • women of child bearing age
  • extremes of body weight > 20kg
  • management of bleeding
19
Q

What are the general measures taken in patients on DOACs who start bleeding?

A
  • assess severity of bleeding
  • assess degree of anticoagulant effect
  • discontinue drug unless bleeding is minor
20
Q

Which drug is the antidote for dabigatran?

A

idarucizumab

antibody that binds to dabigatran with high affinity to prevent interaction with thrombin

21
Q

How does aspirin work?

A
  • inactivates platelet cyclooxygenase reducing thromboxane A2
  • stops platelet activation
  • irreversible events, no reversal agents
22
Q

If you are vitamin K deficient, you are deficient in which factors?

A

Factors II, VII, IX, X

23
Q

What are the causes and treatment of vitamin K deficiency?

A

Causes: obstructive jaundice, prolonged nutritional deficiency, broad spectrum antibiotics, neonates

Treatment: IV/ oral vitamin K

24
Q

What impact would liver disease have on haemostasis?

A
  • thrombocytopenia (production or hypersplenism)
  • platelet dysfunction
  • reduced plasma concentration of all coagulation factors
  • excessive plasmin activity
  • delayed fibrin
25
Q

What are 3 causes of bleeding in renal disease?

A
  1. Anaemia
    - decreased platelet interaction with vascular lining
    - platelet function reduced
  2. Drugs accumulating in renal failure can bind to platelets and block their receptors
  3. Uremia
    - disrupt plt-plt and plt-vessel wall interaction
26
Q

What defines a major haemorrhage

A 
HR> 110
systolic BP < 90mmHg
and/or
transfusion of a volume equal to the patients total blood volume in less than 24 hours or
50% blood volume loss within 3 hours
27
Q

How would LTHT handle a major haemorrage?

A
  • take baseline blood samples prior to transfusion e.g FBC, U&E etc
  • administer RBC: FFP in 1:1 ratio
  • prevent hypothermia: keep patient warm
  • consider administering tranexamic acid
28
Q

What is DIC?

A
  • disseminated intravascular coagulation
  • characterised by systemic activation of pathways leading to and regulating coagulation, which can result in the generation of fibrin clots that may cause organ failure with consumption of platelets and coagulation factors that may result in clinical bleeding
29
Q

Explain the pathogenesis of DIC

A
  • excess thrombin generation
  • reduced natural anticoagulant activity
  • decreased fibrinolysis
30
Q

What are the causes of acute DIC?

A
  • sepsis
  • obstetric complications
  • trauma/tissue necrosis/fat embolism
  • massive blood loss
  • fulminant liver disease
31
Q

What are the causes of chronic DIC/

A

malignancy
end stage liver disease
vascular abnormalities

32
Q

What are the clinical features of DIC?

A
  • mucosal oozing, bleeding from surgical wounds or indwelling canulae
  • multi organ failure secondary to microthrombi
  • skin necrosis
  • thrombus
33
Q

How do we treat DIC?

A
  • treat underlying cause e.g chemotherapy
  • maintain tissue perfusion
  • folic acid and vitK
  • platelet transfusion if platelets < 50
  • fibrinogen

Clinical Pathology (57 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2024 Bold Learning Solutions. Terms and Conditions